Hillhouse-backed GenScript ProBio to raise $224 mln from Legend Capital, others

GenScript ProBio, a pharmaceutical research and manufacturing service provider backed by Hillhouse Investment, will raise $224 million from investors led by Legend Capital, its majority shareholder GenScript Biotech said.

admin